Drugs and drug targets against malaria

Current Science

Volumn 92, Issue 11, 2007, Pages 1545-1555

  Padmanaban, Govindarajan ^a   Nagaraj, V Arun ^a   Rangarajan, Pundi N ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Artemisinin; Drug molecules; Drug targets; Malaria parasite

Indexed keywords

EID: 34347256057     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (105)

1. Morgan, D. O., Cyclin-dependent kinases: Engines, clocks and microprocessors. Annu. Rev. Cell Dev. Biol., 1997, 13, 261-291.
2. Waters, N. C. and Geyer, J. A., Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug development. Expert Opin. Ther. Targets, 2003, 7, 7-17.
3. Keenan, S. M., Geyer, J. A., Welsh, W. J., Prigge, S. T. and Waters, N. C., Rational inhibitor design and iterative screening in the identification of selective plasmodial cyclin dependent kinase inhibitors. Combinatorial Chem. High Throughput Screening, 2005, 8, 27-38.
4. Shuttleworth, J., The regulation and functions of cdk7. Prog. Cell Cycle Res., 1995, 1, 229-240.
5. Kaldis, P. and Solomon, M. J., Analysis of CAK activities from human cells. Eur. J. Biochem., 2000, 267, 4213-4221.
6. Li, J. L., Robson, K. J., Chen, J. L., Targett, G. A. and Baker, D. A., Pfmrk, a MO I5-related protein kinase from Plasmodium falciparum. Gene cloning, sequence, stage-specific expression and chromosome localization. Eur. J. Biochem., 1996, 241, 805-813. (erratum Eur. J. Biochem., 1997, 243, 537).
7. Waters, N. C., Woodward, C. L. and Prigge, S. T., Cyclin H activation and drug susceptibility of the Pfmrk cyclin-dependent protein kinase from Plasmodium falciparum. Mol. Biochem. Parasitol., 2000, 107, 45-55.
8. Wilson, R. J. M. et al., Complete gene map of the plastid-like DNA of the malaria parasite Plasmodium falciparum. J. Mol. Biol., 1996, 261, 155-172.
9. Wilson, R. J. M., Parasite plastids: approaching the end game. Biol. Rev., 2005, 80, 129-153.
10. Waller, R. F. et al., Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. Proc. Natl. Acad. Sci. USA, 1998, 95, 12352-12357.
11. Waller, R. F. et al., Protein trafficking to the plastid of Plasmodium falciparum is via the secretory pathway. EMBO J., 2000, 19, 1794-1802.
12. Bruce, B. D., Chloroplast transit peptides: structure, function and evolution. Trends Cell Biol., 2000, 10, 440-447.
13. Foth, B. J. et al., Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum. Science, 2003, 299, 705-708.
14. Gardner, M. J. et al., Genome sequence of the human malaria parasite Plasmodium falciparum. Nature, 2002, 419, 498-511.
15. Gardner, M. J. et al., Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum. Science, 1998, 282, 1126-1132.
16. Harwood, J. L., Recent advances in the biosynthesis of plant fatty acids. Biochem. Biophys. Acta, 1996, 1301, 7-56.
17. Foth, B. J. and McFadden, G. I., The apicoplast: A plastid in Plasmodium falciparum and other apicomplexan parasites. Int. Rev. Cytol., 2003, 224, 57-110.
18. Jelenksa, J., Crawford, M. J., Harb, O. S., Zuther, E., Haselkorn, R., Roos, D. S. and Gornicki, P., Subcellular localization of acetyl-CoA carboxylase in the apicomplexan parasite Toxoplasma gondii. Proc. Natl. Acad. Sci. USA, 2001, 98, 2723-2728.
19. Zhang, H., Tweel, B. and Tong, L., Molecular basis for the inhibition of the carboxyltransferase domain of acetyl-coenzyme A carboxylase by haloxyfop and diclofop. Proc. Natl. Acad. Sci. USA, 2004, 101, 5910-5915.
20. Waters, N. C. et al., Functional characterization of the acyl carrier protein (PfACP) and beta-ketoacyl ACP synthase III (PfKAS III) from Plasmodium falciparum. Mol. Biochem. Parasitol., 2002, 123, 85-94.
21. Campbell, J. W. and Cronan Jr., J. E., Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery. Annu. Rev. Microbiol., 2001, 55, 305-332.
22. McCleod, R. et al., Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan FabI. Int. J. Parasitol., 2001, 31, 109-113.
23. Surolia, N. and Surolia, A., Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nature Med., 2001, 7, 167-173.
24. Muench, S. P., Rafferty, J. B., McCleod, R., Rice, D. W. and Prigge, S. T., Expression, purification and crystallization of the Plasmodium falciparum enoyl reductase. Acta Crystallogr., 2003, D59, 1246-1248.
25. Kapoor, M., Reddy, C. C., Krishnasastry, M. V., Surolia N. and Surolia, A., Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan. Biochem. J., 2004, 381, 719-724.
26. Lu, J. Z., Lee, P. J., Waters, N. C. and Prigge, S. T., Fatty acid synthesis as a target for antimalarial drug discovery. Combinatorial Chem. High Throughput Screening, 2005, 8, 15-26.
27. Perozzo, R. et al., Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase. J. Biol. Chem., 2002, 277, 13106-13114.
28. Price, A. C., Choi, K.-H., Heath, R. J., Li, Z., White, S. W. and Rock, C. O., Inhibition of b-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism. J. Biol. Chem., 2001, 276, 6551-6559.
29. Sharma, S. K. et al., Identification, characterization and inhibition of Plasmodium falciparum β-hydroxy-acyl carrier protein dehydratase (Fab Z). J. Biol. Chem., 2003, 278, 45661-45671.
30. Swarna Mukhi, P. L., Sharma, S. K., Kapoor, M., Surolia, N., Surolia, A. and Suguna, K., Crystallization and preliminary crystallographic analysis of β-hydroxy acyl ACP dehydratase (Fab Z) from Plasmodium falciparum. Acta Crystallogr., Section D - Biol. Crystallogr., 2004, 60, 120-121.
31. Jomaa, H. et al., Inhibitors of the non-mevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science, 1999, 285, 1573-1576.
32. Ralph, S. A. et al., Metabolic maps and functions of the Plasmodium falciparum apicoplast. Nature Rev. Microbiol., 2004, 2, 203-216.
33. Chakrabarti, D., Da Silva, T., Barger, J., Paquette, S., Patel, H., Patterson, S. and Allen, C. M., Protein farnesyltransferase and protein prenylation in Plasmodium falciparum. J. Biol. Chem., 2002, 277, 42066-42073.
34. Missinoll, A. M. et al., Fosidomycin for malaria. Lancet, 2002, 360, 1941-1942.
35. Lell, B. et al., Fosidomycin, a novel chemotherapeutic agent for malaria. Antimicrob. Agents Chemother., 2003, 47, 735-738.
36. Wiesner, J., Henschker, D., Hutchinson, D. B., Beck, E. and Jomaa, H., In vitro and in vivo synergy of fosidomycin a novel antimalarial drug, with clindamycin. Antimicrob. Agents Chemother. 2002, 46, 2889-2894.
37. Surolia, N. and Padmanaban, G., De novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite. Biochem. Biophys. Res. Commun., 1992, 187, 744-750.
38. Grimm, B., Novel insights in the control of tetrapyrrole metabolism of higher plants. Curr. Opin. Plant Biol., 1998, 1, 245-250.
39. Bonday, Z. Q., Taketani, S., Gupta, P. D. and Padmanaban, G., Heme biosynthesis by the malarial parasite. J. Biol. Chem., 1997, 272, 21839-21846.
40. Bonday, Z. Q., Dhanasekaran, S., Rangarajan, P. N. and Padmanaban, G., Import of host d-aminolevulinate dehydratase into the malarial parasite: Identification of a new drug target. Nature Med., 2000, 6, 898-903.
41. Varadharajan, S., Sagar, B. K. C., Rangarajan, P. N. and Padmanaban, G., Localization of ferrochelatase in Plasmodium falciparum. Biochem. J., 2004, 384, 429-436.
42. Varadharajan, S., Dhanasekaran, S., Bonday, Z. Q., Rangarajan, P. N. and Padmanaban, G., Involvement of δ-aminolevulinate synthase encoded by the parasite gene in de novo haem synthesis by Plasmodium falciparum. Biochem. J., 2002, 367, 321-327.
43. Sato, S., Clough, B., Coates, L. and Wilson, R. J. M., Enzymes for heme biosynthesis are found in both the mitochondrion and plastid of the malaria parasite Plasmodium falciparum. Protist, 2004, 155, 117-125.
44. Dhanasekaran, S., Chandra, N. R., Sagar, B. K. C., Rangarajan, P. N. and Padmanaban, G., δ-Aminolevulinic acid dehydratase from Plasmodium falciparum - indigenous vs imported. J. Biol. Chem., 2004, 279, 6934-6942.
45. Van Dooren, G. G., Stimmler, L. M. and McFadden, G. I., Metabolic maps and functions of the Plasmodium mitochondrion. FEMS Microbiol. Rev., 2006, 30, 596-630.
46. Clough, B. and Wilson, R. J. M., Antibiotics and the plasmodial plastid organelle. In Antimalarial Chemotherapy: Mechanisms of Action, Resistance and New Directions in Drug Discovery (ed. Rosenthal, P. J.), Humana Press, Totawa, 2001, pp. 265-286.
47. Fichera, M. E. and Roos, D. S., A plastid organelle as a drug target in apicomplexan parasite. Nature, 1997, 390, 407-409.
48. Wei, Y., Yi, T., Huntington, K. M., Chaudbuty, C. and Pei, D., Identification of a potent peptide deformylase inhibitor from a rationally designed combinatorial library. J. Combinatorial Chem., 2000, 2, 650-657.
49. Hackbarth, C. J. et al., N-Alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity. Antimicrob. Agents Chemother., 2002, 46, 2752-2764.
50. Surolia, N. and Padmanaban, G., Chloroquine inhibits heme-dependent protein synthesis in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA, 1991, 88, 4786-4790.
51. Lell, B. and Kremsner, P. G., Clindamycin as an antimalrial drug; review of clinical trials. Antimicrob. Agents Chemother., 2002, 46, 2315-2320.
52. Ohrt, C., Willingmyre, G. D., Lee, P. J., Knirsch, C. and Milhous, W. K., Assessment of drugs against Plasmodium falciparum in vitro. Antimicrob. Agents Chemother., 2002, 46, 2518-2524.
53. Ellis, K. E. S., Clough, B., Saldhana, J. W. and Wilson, R. J. M., Nifs and Sufs in malaria. Mol. Microbiol., 2001, 41, 973-981.
54. Tokumoto, U. et al., Network of protein-protein interactions among iron-sulfur cluster assembly proteins in Escherichia coli. J. Biochem., 2002, 131, 713-719.
55. Thomsen-Zieger, N., Shachtner, J. and Seeber, F., Apicomplexan parasites contain a single lipoic acid synthase located in the plastid. FEBS Lett., 2003, 547, 80-86.
56. Gunther, S., McMillan, P. J., Wallace, L. J. M. and Muller, S., Plasmodium falciparum possesses organelle-specific α-kekto acid dehydrogenase complexes and lipoylation pathways. Biochem. Soc. Trans., 2005, 33, 977-980.
57. Krungkrai, J., Prapunwattana, P. and Krungkrai, S. R., Ultrastructure and function of mitochondria in gametocytic stage of Plasmodium falciparum. Parasite, 2000, 7, 19-26.
58. Aldritt, S. M., Joseph, J. T. and Wirth, D. F., Sequence identification of cytochrome b in Plasmodium gallinaceum. Mol. Cell Biol., 1989, 9, 3614-3620.
59. Feagin, J. E., Mericle, B. L., Werner, E. and Morris, M., Identification of additional rRNA fragments encoded by the Plasmodium falciparum 6 kb element. Nucleic Acids Res., 1997, 25, 438-446.
60. Painter, H. J., Morrisey, J. M., Mather, M. W. and Vaidya, A. B., Specific role of mitochondrial electron transport in blood stage Plasmodium falciparum. Nature, 2007, 446, 88-91.
61. Li, W. et al., Yeast model uncovers dual roles of mitochondria in the action of artemisinin. PLOS Genet., 2005, 1, e36.
62. Vaidya, A. B., Atavaquone-proguanil combination. In Antimalarial Chemotherapy: Mechanisms of Action, Resistance and New Directions in Drug Discovery (ed. Rosenthal, P. J.), Totawa, Humana Press, 2001, pp. 203-218.
63. Fujihashi, M. et al., An unprecedental twist to ODCase catalytic activity. J. Am. Chem. Soc., 2005, 127, 15048-15050.
64. Hall, Nl. et al., A comprehensive survey of the Plasmodium life cycle of genomic, transcriptomic and proteomic analyses. Science, 2005, 307, 82-86.
65. Khan, S. M. et al., Proteomic analysis of separated male and female gametocytes reveals novel sex-specific Plasmodium biology. Cell, 2005, 121, 675-687.
66. Plowe, C. V., Folate antagonist and mechanisms of resistance. In Antimalarial Chemotherapy: Mechanism of Action, Resistance and New Directions in Drug Discovery (ed. Rosenthal, P. J.), Humana Press, Totowa, 2001, pp. 173-190.
67. Mutabingwa, T., Nzila, A., Mberu, E., Nduati, E., Winstanley, P., Hills, E. and Watkins, W., Chloroproguanil for treatment of drug-resistant falciparum malaria in Tanzania. Lancet, 2001, 358, 1218-1223.
68. Biagini, G. A., O'Neill, P. M., Nzila, A., Ward, S. A. and Bray, P. G., Young guns or back to the future. Trends Parasitol., 2003, 19, 479-487.
69. Brady, R. L. and Cameron, A., Structure-based approaches to the development of antimalarials. Curr. Drug Targets, 2004, 5, 137-149.
70. Parthasarathy, S., Ravindra, G., Balaram, H., Balaram, P. and Murthy, M. R. N., Structure of the Plasmodium falciparum triosephosphate isomerase-phosphoglycolate complex in two crystal forms. Characterization of catalytic loop open and closed conformations of the ligand-bound state. Biochemistry, 2002, 41, 13178-13188.
71. Shi, W. et al., Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors and dual catalytic function. J. Biol. Chem., 2004, 279, 18103-18106.
72. Li, C. et al., Transition state analogs as inhibitors of human and malarial hypoxanthine-guanine phosphoribosyltransferases. Nature Struct. Biol., 1999, 6, 582-587.
73. Subbayya, I. N. S. and Balaram, H., Evidence for multiple active states of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyl transferase. Biochem. Biophys. Res. Commun., 2000, 279, 433-437.
74. Eaazhisai, K., Jayalakshmi, R., Gayathri, P., Anand, R. P., Sumathy, K., Balaram, H. and Murthy, M. R. N., Crystal structure of fully ligated adenylosuccinate synthetase from Plasmodium falciparum. J. Mol. Biol., 2004, 335, 1251-1264.
75. Fritz-wolf, K. et al., X-ray structure of glutathione-S- transferase from the malarial parasite Plasmodium falciparum. Proc. Natl. Acad. Sci. USA, 2003, 100, 13821-13826.
76. Muller, S., Liebau, E., Walter, R. D. and Krauth-Siegel, Thiol based redox metabolism of protozoan parasites. Trends Parasitol., 2003, 19, 320-328.
77. Roberts, F. et al., Evidence for the shikimate pathway in apicomplexan parasites. Nature, 1998, 393, 801-805.
78. Fitzpatrick, T., Rickew, S., Lanzer, M., Amrhein, N., Macheroux, P.and Kappes, B., Subcellular localization and characterization of chorismate synthase in the apicomplexan Plasmodium falciparum. Mol. Microbiol., 2001, 40, 65-75.
79. McConkey, G. A., Pinney, J. W., Westhead, D. R., Plueckhahn, K., Fitzpatrick, T. B., Macheroux, P. and Kappes, B., Annotating the Plasmodium genome and the shikimate pathway. Trends Parasitol., 2004, 20, 60-65.
80. Banerjee, R., Liu, J., Beatty, W., Pelosof, L., Klemba, M. and Goldberg, D. E., Four plasmepsins are active in Plasmodium falciparum including a protease with an active site histidine. Proc. Natl. Acad. Sci. USA, 2002, 99, 990-995.
81. Sijwalai, P. S. and Rosenthal, P. J., Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum. Proc. Natl. Acad. Sci. USA, 2004, 101, 4384-4389.
82. Pagola, S., Stephens, P. W., Bhole, D. S., Kosar, A. D. and Madsen, S. K., The structure of malaria pigment β-haematin. Nature, 2000, 404, 307-310.
83. Tekwani, B. L. and Walker, L. A., Targeting for hemozoin synthesis pathway for new antimalarial drug discovery: Technologies for in vitro β-hematin formation assay. Combinatorial Chem. High Throughput Screening, 2005, 8, 63-79.
84. Buller, R., Peterson, M. L., Almarsson, O. and Leiserowitz, L., Quinoline binding site on malarial pigment crystal: A rational pathway for antimalarial design. Crystal Growth Design, 2002, 2, 553-562.
85. Pandey, A. V., Tekwani, B. L., Singh, R. L. and Chauhan, V. S., Artemisinin, an endoperoxide antimalarial disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite. J. Biol. Chem., 1999, 274, 19383-19388.
86. Eckstein-Ludwig, U. et al., Artemisinins target the SERCA of Plasmodium falciparum. Nature, 2003, 424, 957-960.
87. Kurosawa, Y. et al., Hematin polymerization assay as a high throughput screen for identification of new antimalarial pharmacophores. Antimicrob. Agents Chemother., 2000, 44, 2638-2644.
88. Eggleson, K. K., Duffin, K. L. and Goldberg, D. E., Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malarial parasite Plasmodium falciparum. J. Biol. Chem., 1999, 274, 32411-32417.
89. Rosenthal, P. J., Hydrolysis of erythrocyte proteins by proteases of malarial parasites. Curr. Opin. Hematol., 2002, 9, 140-145.
90. Deprez-Poulani, R. and Melnyk, P., 1,4-Bis(3-aminopropyl) piperazine libraries: From the discovery of classical chloroquine-like antimalarials to the identification of new targets. Combinatorial Chem. High Throughput Screening, 2005, 8, 39-48.
91. Chen, X., Chong, C. R., Shi, L., Yoshimoto, T., Sullivan Jr., D. and Liu, J. O., Inhibitor of Plasmodium falciparum aminopeptidase 1b possess antimalarial activity. Proc. Natl. Acad. Sci. USA, 2006, 103, 14548-14553.
92. Vial, H. and Ancelin, M., Malarial lipids. In Malaria: Parasite Biology, Biogenesis, Protection, ASM Press, Washington DC, 1998, pp. 159-175.
93. Calas, M., Ancelin, M. L., Cordma, G., Portefaix, P., Piquet, G., Vidal-Sailhan, V. and Vial, H., Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: comparison between mono- and bis-quaternary ammonium salts. J. Med. Chem., 2000, 43, 505-516.
94. Salom-Roid, X. J., Hamze, A., Calas, M. and Vial, H. J., Dual molecules as new antimalarials. Combinatorial Chem. High Throughput Screening, 2005, 8, 49-62.
95. Staines, H. M., Ellory, J. C. and Chibale, K., The new permeability pathways: Targets and selective routes for the development of new antimalarial agents. Combinatorial Chem. High Throughput Screening, 2005, 8, 81-88.
96. Kirk, K., Membrane transport in the malaria-infected erythrocyte. Physiol. Rev., 2001, 81, 495-537.
97. Staines, H. M. et al., Furosemide analogues as potent inhibitors of the new permeability pathways of Plasmodium falciparum-infected human erythrocytes. Mol. Biochem. Parasitol., 2004, 133, 315-318.
98. Lauer, S. A., Rathod, P. K., Ghori, N. and Haldar, K., A membrane network for nutrient import in red cells infected with malaria parasite. Science, 1997, 276, 1122-1125.
99. Ang, K. K. H., Holmes, M. J., Higa, J., Hamann, M. T. and Kara, U. A. K., In vivo antimalarial activity of the beta-carboline alkaloid Menzamine A. Antimicrob. Agents Chemother., 2000, 44, 1645-1649.
100. Raju, R. C., Vathsala, P. G., Keshamouni, V. G., Padmanaban, G. and Rangarajan, P. N., Curcumin for malaria therapy. Biochem. Biophys. Res. Commun., 2005, 326, 472-474.
101. Nandakumar, D. N., Nagaraj, V. A., Vathsala, P. G., Rangarajan, P. N. and Padmanaban, G., Curcumin-artemisinin combination therapy for malaria. Antimicrob. Agents Chemother., 2006, 50, 1859-1860.
102. Carraz, M. et al., A plant-derived morphinan as a novel lead compound active against malaria liver stages. PLOS Med. 2006, 3, e513.
103. Wicox, M., Bodekar, G. and Raspanaivo, P., Traditional Medicinal Plants and Malaria, CRC Press, Boca Raton, 2004.
104. Vennerstrom, J. L. et al., Identification of an antimalarial synthetic trioxalane drug development candidate. Nature, 2004, 430, 900-904.
105. Posner, G. H. et al., Malaria-infected mice are cured by a single dose of novel artemisinin derivatives. J. Med. Chem., 2007, DOI 10.1021/jm07014m.